• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 84 of 100
Symbolic - biotechnology - genetic engineering
Tech
Guess What This Early Skype Investor Is Betting on Now
By ReutersFebruary 2, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership
Gilead CEO John Martin Is Stepping Down After 20 Years
By Jen WiecznerJanuary 29, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Biotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Key Speakers At The 2015 Dell World Conference
Features
New Barbie and Microsoft Earnings—5 Things to Know Today
By Tom Huddleston Jr. and Geoffrey SmithJanuary 28, 2016
Obama Speaks Before Leaving COP21
Leadership
You’ll Never Guess Who’s Blocking Obama’s FDA Nominee
By Ben GeierJanuary 26, 2016
Johnson & Johnson Products Ahead Of Earnings
Health
Drug Sales Are Driving Johnson & Johnson’s Growth
By Laura LorenzettiJanuary 26, 2016
The Food and Drug Administration
Health
This Cough Syrup Was Recalled Because It Contains Morphine
By Chris MatthewsJanuary 22, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health
Martin Shkreli Is Headed For a Major Showdown With Congress
By ReutersJanuary 22, 2016
BRITAIN-PHARMACEUTICAL-GSK
Finance
Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline
By ReutersJanuary 21, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health
Valeant Vows to Make Its Drugs ‘Affordable’
By Laura LorenzettiJanuary 13, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health
Biosimilars Are Coming After Big Pharma’s Bottom Line
By Laura LorenzettiJanuary 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health
Drugmaker Shire Is Buying Baxalta for $32 Billion
By ReutersJanuary 11, 2016
Pfizer In Merger Talks With Allergan PLC
Health
Pfizer Just Jacked Up Prices for All of These Drugs
By ReutersJanuary 9, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health
Shire’s Merger With Baxalta Merger Is Nearly Done
By ReutersJanuary 8, 2016
<> at Downsview Park on September 20, 2015 in Toronto, Canada.
Arts & Entertainment
Wu-Tang’s RZA Says He Doesn’t Care What Martin Shkreli Does with His Album
By Laura LorenzettiJanuary 6, 2016
1...
  • 82
  • 83
  • 84
  • 85
  • 86
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.